Acorda Therapeutics, Inc.
(NASDAQ:ACOR)|
15.70 -1.61 (-9.30%) Nov 19 - Close |
|
|
|
After-Hours 16.43 +0.73 (4.65%) Wed, 19 Nov 2008 6:50 PM
- Compare ACOR with:
- View: Line | Candlestick
Company Profile
Acorda Therapeutics, Inc.
15 Skyline Drive
Hawthorne, NY 10532
United States - Map
Phone: (914) 347-4300
Fax: (914) 347-4560
Website: www.acorda.com
CEO: Dr. Ron Cohen, M.D.
Employees: 144
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Biopharm company focused on central nervous system
A biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury & other disorders of the central nervous system
Recent news for ACOR
-
ACORDA THERAPEUTICS INC Financials
EDGAR Online Financials - Nov 18 at 9:04 ET
-
Acorda Therapeutics to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
Business Wire - Nov 13 at 7:00 ET
-
Acorda Therapeutics Names Thomas C. Wessel, M.D., Ph.D., as Chief Medical Officer
Business Wire - Nov 12 at 7:00 ET
-
ACORDA THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 10 at 4:28 ET
-
FDA Delays Take Toll on Neuroscience Drug Development
The Wall Street Journal Online - Nov 10 at 4:05 ET
-
Coverage initiated on Acorda Therapeutics by RBC Capital Mkts
Briefing.com - Nov 07 at 9:55 ET
-
New Star Analyst Rankings for ACORDA THERAPEUTICS
StarMine - Nov 05 at 9:30 ET
-
Acorda Therapeutics to Present at the 2008 Deutsche Bank Biotech Boston Confab
Business Wire - Nov 05 at 7:00 ET
-
Acorda Therapeutics, Inc., Q3 2008 Earnings Call Transcript
Seeking Alpha - Nov 04 at 2:12 ET
-
Acorda Therapeutics Earnings Call scheduled for 8:30 am ET today
CCBN - Nov 04 at 8:30 ET